NCT05989295

A Probiotic That Reduces Atopic Skin

The Efficacy, Safety and Acceptability of a Probiotic in Reducing the Scorad Index in Children With Atopic Skin

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 2 Years – 14 Years
• Healthy volunteers: Accepted

Summary

To assess the efficacy and safety of the use of probiotics as food supplements in reducing the SCORAD index in children with atopic skin compared with placebo. This is a randomized, placebo-controlled, double-blind clinical trial with 2 parallel groups, which will include 32 patients who attend some of the research centers. Patients will be randomized into one of the 2 study groups (allocation ratio 1: 1): Experimental group (Lactobacillus rhamnosus LRa05) and placebo group (placebo). The reduction of the SCORAD index, the number of sprouts in 12 weeks, the days of use of topical corticosteroids and one valuations of the skin condition (hydration).

Conditions

• Atopic Skin
• Children

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	probiotic LRa05	treatment about 12 weeks

Timeline

• Start date: 2022-01-26
• Primary completion: 2022-12-01
• Completion: 2023-04-21
• First posted: 2023-08-14
• Last updated: 2023-08-14

Locations

2 sites across 1 country: Spain